Dexmethylphenidate - Celgene/Novartis
At a glance
- Drug Originator Celgene Corporation
- Drug Licenced by Intellipharmaceutics International; Novartis; Par Pharmaceutical Inc
- Drug Class Behavioural disorder therapies; Phenylacetates; Piperidines; Small molecules
- Mechanism of Action Adrenergic receptor agonists; Central nervous system stimulants; Dopamine uptake inhibitors; Neurokinin 1 antagonists; Substance P inhibitors
- USA Patent Applicants SANDOZ
- USA Patents 10
- NDAs 2
- Patent Applications 4,023
Table of Contents
Disclaimer